t should be noted, however, that apparent similarities in the overall use of these therapies through the first 24 h in the ICU does not exclude the distinct possibility that significant EGDT-specific modifications of therapy are still occurring for individual patients. In contrast to studies in the 1990s that targeted supranormal oxygen delivery,